<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to neutrophil cytoplasmic antigens (<z:chebi fb="0" ids="34507">ANCA</z:chebi>) are good serological markers for patients with mainly vasculitic conditions </plain></SENT>
<SENT sid="1" pm="."><plain>Two main types of <z:chebi fb="0" ids="34507">ANCAs</z:chebi> have been detected, the first termed cytoplasmic antineutrophil cytoplasmic antibody (cANCA) are mainly associated with patients with Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>, the other termed perinuclear antineutrophil cytoplasmic antibody (pANCA) are mainly associated with patients with renal <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, rheumatic and <z:e sem="disease" ids="C0009326" disease_type="Disease or Syndrome" abbrv="">collagen disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>These antibodies are against various constituents of neutrophil granules </plain></SENT>
<SENT sid="3" pm="."><plain>In patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo>, defects in <z:mpath ids='MPATH_458'>normal</z:mpath> granulocyte development are seen </plain></SENT>
<SENT sid="4" pm="."><plain>We report a series of twelve patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> of whom at least four showed a low titre and one a high titre of pANCA </plain></SENT>
<SENT sid="5" pm="."><plain>Two of these patients also had demonstrable activity against myeloperoxidase (MPO) </plain></SENT>
<SENT sid="6" pm="."><plain>None of these patients had any evidence of systemic or cutaneous <z:hpo ids='HP_0002633'>vasculitis</z:hpo> or of any <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>There was no pANCA positivity in an age matched control group </plain></SENT>
</text></document>